Bristol Myers Squibb Co. (BMY)
Bristol Myers Squibb Market Cap: 116.08B for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 177.14B |
| Gilead Sciences, Inc. | 153.93B |
| Johnson & Johnson | 526.55B |
| Eli Lilly & Co. | 960.61B |
| Regeneron Pharmaceuticals, Inc. | 79.26B |
Market Cap Related Metrics
| PE Ratio | 19.25 |
| PS Ratio | 2.420 |
| Price to Book Value | 6.257 |
| Price to Free Cash Flow | 7.596 |
| Price | 57.02 |
| Earnings Yield | 5.19% |
| Operating PE Ratio | 8.294 |
| Normalized PE Ratio | 10.85 |